Trial intelligence / Profile preview

Comparison of Three Delivery Methods of Mitomycin-C for Trabeculectomy

NCT03875911Phase 4Terminated

Sponsor
University of California, Los Angeles
Start
Mar 2019
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mitomycin c in primary open-angle glaucoma (POAG), sponsored by University of California, Los Angeles. Started Mar 2019; status: terminated.

02

Drugs

mitomycin c
03

Conditions

primary open-angle glaucoma (POAG)

Beyond the preview

Go deeper on NCT03875911.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03875911.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call